ABOUT THE PACKARD CENTER

Packard Center for ALS Research at Johns Hopkins

  • 90

    EVERY 90 MINUTES A PERSON IN THE U.S. IS DIAGNOSED

ALS Clinical Trials

Listed below are the clinical research studies currently underway or in planning stages at the Johns Hopkins ALS Clinic. 

Research Studies currently enrolling participants:

Generation and Characterization of Cell Lines for ALS
Nicholas Maragakis, MD – Principal Investigator
(Currently only enrolling patients with confirmed familial ALS)
CONTACT: Betsy Mosmiller (p) 410-502-0495 | emosmil1@jhmi.edu

Skin biopsies to generate cell lines for study of ALS
Nicholas Maragakis, MD – Principal Investigator

A Longitudinal Study of Cognition and Behavior in ALS
Chiadi Onyike, MD, MHS – Principal Investigator

A Multicenter Study for the Validation of ALS Biomarkers
Nicholas Maragakis, MD – Principal Investigator

Electrical impedance myography as an outcome measure in ALS clinical trials
Nicholas Maragakis, MD – Principal Investigator

Upcoming trials, not yet enrolling participants:

A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in Patients with ALS.
Andrea Corse, MD – Principal Investigator
Planned Start: late 2009

Safety and Tolerability of the Ketogenic Diet in ALS
Vinay Chaudhry, MD – Principal Investigator
Planned Start: early 2010

No Longer Enrolling Participants, but ongoing studies:

Quality of Life and Caregiver Burden in ALS
Richard Kimball, MSN/MPH APRN PhD(c) – Principal Investigator

A Phase 2 Repeat-Dosing Clinical Trial of SB-509 in Subjects with Amyotrophic Lateral Sclerosis - Sangamo BioSciences, Inc.
Nicholas Maragakis, MD – Principal Investigator

A Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Tolerability and Safety of talampanel in Subjects with ALS
Nicholas Maragakis, MD & Jeff Rothstein, MD – Principal Investigators

A 2-Part, Randomized, Double-Blind, Safety and Tolerability Study Evaluating KNS-760704 in Patients with Amyotrophic Lateral Sclerosis (ALS)
Jeff Rothstein, MD, PhD – Principal Investigator

--------------------------------------------------------------------------------

For information about these clinical trials, please contact
Lora Clawson, MSN, CRNP
Director of ALS Clinical Services
410-955-8511
lclawson@jhmi.edu

--------------------------------------------------------------------------------

Information about other ALS-specific research trials can be found on these websites:

MUSCULAR DYSTROPHY ASSOCIATION
http://www.mda.org/research/ctrials.aspx

ALS ASSOCIATION
http://www.alsa.org/research/drugdev.cfm

 NATIONAL INSTITUTES OF HEALTH
www.clinicaltrials.gov

Events

Johns Hopkins School of Medicine

Contact The Packard Center

© 2010, The Robert Packard Center for ALS Research at Johns Hopkins. All rights reserved.

5801 Smith Avenue, McAuley Suite 110,
Baltimore, Maryland 21209, USA